ELTP Opinions 08/10/2014 22:38:35 $ELTP
He is a CEO LAWYER LOL!!!
He may not be a practicing lawyer but I would think he has a very good working knowledge of the law and how to respond to ludicrous lawsuits.
He's not a PRACTICING lawyer. He has a law degree and that is what matters on this subject.
He's not a lawyer. He's a CEO.
Looks to me like he has a law degree. The following is an excerpt from Nasrat's bio quoted in the Ibox:
"and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL."
Impressive.
Elite could not have chosen a better CEO>
ELTP
Mr. Nasrat Hakim has been the Chief Executive Officer and President of Elite Pharmaceuticals, Inc. since August 1, 2013.
Businessweek.com
http://investing.businessweek.com/research/st...icker=ELTP
Mr. Nasrat Hakim has been the Chief Executive Officer and President of Elite Pharmaceuticals, Inc. since August 1, 2013. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He has a proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. He served as a Vice President of Quality Compliance and Technical Services at Actavis LLC. Mr. Hakim served as Vice President of Quality of Alexza Pharmaceuticals Inc. since July 18, 2007. Mr. Hakim served as Corporate Vice President of Quality and Compliance for Actavis / Alpharma Inc., and previously served as Global Vice President of Compliance for Alpharma, where he was employed from 2004 to 2007. He has been a Director at Elite Pharmaceuticals, Inc since August 1, 2013. Mr. Hakim has also served as Executive Director of Corporate Compliance and Technical Projects for Watson Pharmaceuticals and Executive Director, Site Head of Quality and Compliance at TheraTech, Inc. Watson Pharmaceuticals acquired TheraTech in 1999. Mr. Hakim holds both a JD and BS in Law from Saratoga University in San Jose, California, a Masters degree (LLM) in Law from St. Thomas University in Miami, Florida and Bachelors and Masters degrees in Chemistry from California State University at Sacramento.
Which ADT opiod is to be filed with FDA this year?
1) ELI-200
2) ELI-201
3) ELI-202
My friend sat right next to him in Law School. lol
The bogus one that remains unnamed and unknown. Yes, I did say bogus and until CEO provides the name and the basis for evaluation the evaluation remains bogus.
More misinformation
LMAO, now that's funny.
ELTP
Congrats! I will. I will continue accumulating right up until right BEFORE first ADT launch NEXT year.
ELTP my ticket to the good life
Can't call. The CC's are always held in the middle of the work day.
Since you need full disclosure, call during the CC and ask NH your question. Easy.
Quote:
the next inevitable run that will occur. My bet is the next run we blow past .97
Best of luck.
Good for us because as of now that information is not of the ELTP shareholders concern.
All speculatives and few facts = .30; still overvalued.
He is a CEO LAWYER LOL!!!
He may not be a practicing lawyer but I would think he has a very good working knowledge of the law and how to respond to ludicrous lawsuits.
He's not a PRACTICING lawyer. He has a law degree and that is what matters on this subject.
He's not a lawyer. He's a CEO.
Looks to me like he has a law degree. The following is an excerpt from Nasrat's bio quoted in the Ibox:
"and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL."
Impressive.
Elite could not have chosen a better CEO>
ELTP
Mr. Nasrat Hakim has been the Chief Executive Officer and President of Elite Pharmaceuticals, Inc. since August 1, 2013.
Businessweek.com
http://investing.businessweek.com/research/st...icker=ELTP
Mr. Nasrat Hakim has been the Chief Executive Officer and President of Elite Pharmaceuticals, Inc. since August 1, 2013. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He has a proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. He served as a Vice President of Quality Compliance and Technical Services at Actavis LLC. Mr. Hakim served as Vice President of Quality of Alexza Pharmaceuticals Inc. since July 18, 2007. Mr. Hakim served as Corporate Vice President of Quality and Compliance for Actavis / Alpharma Inc., and previously served as Global Vice President of Compliance for Alpharma, where he was employed from 2004 to 2007. He has been a Director at Elite Pharmaceuticals, Inc since August 1, 2013. Mr. Hakim has also served as Executive Director of Corporate Compliance and Technical Projects for Watson Pharmaceuticals and Executive Director, Site Head of Quality and Compliance at TheraTech, Inc. Watson Pharmaceuticals acquired TheraTech in 1999. Mr. Hakim holds both a JD and BS in Law from Saratoga University in San Jose, California, a Masters degree (LLM) in Law from St. Thomas University in Miami, Florida and Bachelors and Masters degrees in Chemistry from California State University at Sacramento.
Which ADT opiod is to be filed with FDA this year?
1) ELI-200
2) ELI-201
3) ELI-202
My friend sat right next to him in Law School. lol
The bogus one that remains unnamed and unknown. Yes, I did say bogus and until CEO provides the name and the basis for evaluation the evaluation remains bogus.
More misinformation
LMAO, now that's funny.
ELTP
Congrats! I will. I will continue accumulating right up until right BEFORE first ADT launch NEXT year.
ELTP my ticket to the good life
Can't call. The CC's are always held in the middle of the work day.
Since you need full disclosure, call during the CC and ask NH your question. Easy.
Quote:
the next inevitable run that will occur. My bet is the next run we blow past .97
Best of luck.
Good for us because as of now that information is not of the ELTP shareholders concern.
All speculatives and few facts = .30; still overvalued.
